title: Are current clinical trials in diabetes addressing important issues in diabetes care?
abstract: OBJECTIVE
  Clinical trials assessing interventions for treating and preventing diabetes mellitus and its complications are needed to inform evidence-based practice. To examine whether current studies adequately address these needs, we conducted a descriptive analysis of diabetes-related trials registered with ClinicalTrials.gov from 2007 to 2010.
  
  
  METHODS
  From a dataset including 96,346 studies registered in ClinicalTrials.gov downloaded on 27 September, 2010, a subset of 2,484 interventional trials was created by selecting trials with disease condition terms relevant to diabetes.
  
  
  RESULTS
  Of the diabetes-related trials, 74.8% had a primarily therapeutic purpose while 10% were preventive. Listed interventions included drugs (63.1%) and behavioural (11.7%). Most trials were designed to enrol ≤ 500 (91.1%) or ≤ 100 (58.6%) participants, with mean/median times to completion of 1.8/1.4 years. Small percentages of trials targeted persons aged ≤ 18 years (3.7%) or ≥ 65 years (0.6%), while 30.8% excluded patients >65 years and the majority excluded those >75 years. Funding sources included industry (50.9%), NIH (7.5%) or other, with most being single-centre trials of other sponsorship (37.7%) or industry-funded multicentre studies (27.4%). A small number of trials (1.4%) listed primary outcomes including mortality or clinically significant cardiovascular complications. The distribution of trials by global region and US state does not correlate with prevalence of diabetes.
  
  
  CONCLUSIONS
  The majority of diabetes-related trials include small numbers of participants, exclude those at the extremes of age, are of short duration, involve drug therapy rather than preventive or non-drug interventions and do not focus upon significant cardiovascular outcomes. Recently registered diabetes trials may not sufficiently address important diabetes care issues or involve affected populations.
authors.affiliation: Division of Endocrinology, Metabolism and Nutrition, Duke University Medical Center, DUMC Box 3850, 2400 Pratt Street, Room 7039, North Pavilion, Durham, NC 27705, USA.
authors.forename: W C
authors.initials: WC
authors.lastname: Lakey
authors.forename: K
authors.initials: K
authors.lastname: Barnard
authors.forename: B C
authors.initials: BC
authors.lastname: Batch
authors.forename: K
authors.initials: K
authors.lastname: Chiswell
authors.forename: A
authors.initials: A
authors.lastname: Tasneem
authors.forename: J B
authors.initials: JB
authors.lastname: Green
mesh_terms: D002318:Cardiovascular Diseases / Q000150:complications / Q000517:prevention & control; D002986:Clinical Trials as Topic; D048909:Diabetes Complications / Q000628:therapy; D003920:Diabetes Mellitus / Q000628:therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D012107:Research Design; D016896:Treatment Outcome; D014481:United States
references.citation: N Engl J Med. 1993 Sep 30;329(14):977-86
references.pmid: 8366922
references.citation: J Clin Endocrinol Metab. 2010 Apr;95(4):1566-74
references.pmid: 20194712
references.citation: JAMA. 2010 Aug 11;304(6):649-56
references.pmid: 20699456
references.citation: Diabetes Care. 2012 Jun;35(6):1380-7
references.pmid: 22619289
references.citation: Lancet. 2006 Sep 23;368(9541):1096-105
references.pmid: 16997664
references.citation: Arch Intern Med. 1999 Nov 8;159(20):2470-5
references.pmid: 10665896
references.citation: Diabet Med. 2007 May;24(5):451-63
references.pmid: 17470191
references.citation: N Engl J Med. 2010 Apr 22;362(16):1477-90
references.pmid: 20228403
references.citation: N Engl J Med. 2009 Jan 8;360(2):129-39
references.pmid: 19092145
references.citation: Am J Ophthalmol. 2006 Mar;141(3):446-455
references.pmid: 16490489
references.citation: Diabetologia. 2009 Sep;52(9):1766-77
references.pmid: 19572116
references.citation: JAMA. 2004 Sep 15;292(11):1363-4
references.pmid: 15355936
references.citation: Lancet. 1998 Sep 12;352(9131):837-53
references.pmid: 9742976
references.citation: JAMA. 2012 May 2;307(17):1838-47
references.pmid: 22550198
references.citation: Lancet. 2002 Jun 15;359(9323):2072-7
references.pmid: 12086760
references.citation: Ann Intern Med. 2006 Apr 4;144(7):465-74
references.pmid: 16585660
references.citation: JAMA. 2002 May 15;287(19):2519-27
references.pmid: 12020332
references.citation: N Engl J Med. 2008 Jun 12;358(24):2545-59
references.pmid: 18539917
references.citation: N Engl J Med. 2007 Jun 14;356(24):2457-71
references.pmid: 17517853
references.citation: J Clin Endocrinol Metab. 2011 Jul;96(7):2027-31
references.pmid: 21734003
references.citation: Ann Epidemiol. 2008 Mar;18(3):222-9
references.pmid: 18201902
references.citation: N Engl J Med. 2002 Feb 7;346(6):393-403
references.pmid: 11832527
references.citation: Arch Intern Med. 2008 Apr 28;168(8):820-5
references.pmid: 18443256
references.citation: PLoS One. 2012;7(3):e33677
references.pmid: 22438982
references.citation: N Engl J Med. 2008 Oct 9;359(15):1577-89
references.pmid: 18784090
references.citation: Diabetologia. 2009 Sep;52(9):1699-708
references.pmid: 19597799
references.citation: N Engl J Med. 2008 Jun 12;358(24):2560-72
references.pmid: 18539916